Covered recipient · General Payments record
KEVIN L WINTHROP
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,773,497.23
- Reported across 606 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $394,928.80 | 81 |
| Travel and Lodging | $15,164.25 | 16 |
| Food and Beverage | $1,090.33 | 10 |
| Grant | $985.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $105,435.00 | 4 |
| ABBVIE INC. | $87,987.98 | 26 |
| UCB SA | $37,010.00 | 6 |
| Moderna TX, Inc. | $32,550.00 | 9 |
| Genentech, Inc. | $31,760.00 | 9 |
| Eli Lilly and Company | $27,220.18 | 10 |
| GlaxoSmithKline, LLC. | $21,659.95 | 10 |
| SANOFI US SERVICES INC. | $12,070.00 | 2 |
| Janssen Research & Development, LLC | $12,006.66 | 6 |
| BioMarin Pharmaceutical Inc. | $8,550.00 | 2 |
| F. Hoffmann-La Roche AG | $7,987.50 | 2 |
| Insmed, Inc. | $7,187.73 | 9 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $7,150.00 | 3 |
| Zambon USA Ltd. | $3,684.64 | 3 |
| Acerta Pharma LLC | $3,575.00 | 1 |
| AstraZeneca UK Limited | $3,087.50 | 2 |
| Gilead Sciences, Inc. | $2,529.94 | 2 |
| Partner Therapeutics, Inc. | $710.00 | 1 |
| PFIZER INC. | $6.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (108)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $800.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349292 | CMS |
| ABBVIE INC. | $5,680.00 | 01/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349294 | CMS |
| ABBVIE INC. | $3,195.00 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349296 | CMS |
| ABBVIE INC. | $3,905.00 | 02/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349298 | CMS |
| ABBVIE INC. | $710.00 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349300 | CMS |
| ABBVIE INC. | $6,035.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349302 | CMS |
| ABBVIE INC. | $3,600.00 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349304 | CMS |
| ABBVIE INC. | $4,400.00 | 08/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349306 | CMS |
| ABBVIE INC. | $800.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349308 | CMS |
| ABBVIE INC. | $800.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349310 | CMS |
| ABBVIE INC. | $3,200.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349312 | CMS |
| ABBVIE INC. | $5,600.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349314 | CMS |
| ABBVIE INC. | $1,600.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349316 | CMS |
| ABBVIE INC. | $800.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349318 | CMS |
| ABBVIE INC. | $1,000.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349320 | CMS |
| ABBVIE INC. | $15,200.00 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349322 | CMS |
| ABBVIE INC. | $800.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349324 | CMS |
| ABBVIE INC. | $6,800.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349326 | CMS |
| ABBVIE INC. | $3,200.00 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349328 | CMS |
| ABBVIE INC. | $10,000.00 | 10/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106349330 | CMS |
| ABBVIE INC. | $13.38 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106349332 | CMS |
| ABBVIE INC. | $21.99 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106349334 | CMS |
| ABBVIE INC. | $9,600.00 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106349336 | CMS |
| ABBVIE INC. | $20.10 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106349338 | CMS |
| ABBVIE INC. | $71.67 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106349340 | CMS |
| ABBVIE INC. | $135.84 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106349342 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,575.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105621923 | CMS |
| AstraZeneca UK Limited | $2,600.00 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093925254 | CMS |
| AstraZeneca UK Limited | $487.50 | 08/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094019206 | CMS |
| BioMarin Pharmaceutical Inc. | $5,175.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1127062952 | CMS |
| BioMarin Pharmaceutical Inc. | $3,375.00 | 10/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1127058175 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28,400.00 | 03/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101345853 | CMS |
| E.R. Squibb & Sons, L.L.C. | $29,465.00 | 04/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101345859 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22,720.00 | 04/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101345861 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24,850.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101345897 | CMS |
| Eli Lilly and Company | $133.38 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135078187 | CMS |
| Eli Lilly and Company | $277.80 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135104485 | CMS |
| Eli Lilly and Company | $329.00 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135104487 | CMS |
| Eli Lilly and Company | $69.91 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135104489 | CMS |
| Eli Lilly and Company | $133.38 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135104491 | CMS |
| Eli Lilly and Company | $329.00 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135111594 | CMS |
| Eli Lilly and Company | $277.80 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135133114 | CMS |
| Eli Lilly and Company | $69.91 | 02/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135134066 | CMS |
| Eli Lilly and Company | $15,200.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135078189 | CMS |
| Eli Lilly and Company | $10,400.00 | 10/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135111596 | CMS |
| F. Hoffmann-La Roche AG | $3,727.50 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048223 | CMS |
| F. Hoffmann-La Roche AG | $4,260.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048219 | CMS |
| Genentech, Inc. | $3,900.00 | 02/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048227 | CMS |
| Genentech, Inc. | $5,200.00 | 03/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048231 | CMS |
| Genentech, Inc. | $2,840.00 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048248 | CMS |
| Genentech, Inc. | $5,200.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048252 | CMS |
| Genentech, Inc. | $3,275.00 | 05/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048235 | CMS |
| Genentech, Inc. | $1,282.50 | 08/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048256 | CMS |
| Genentech, Inc. | $5,362.50 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048244 | CMS |
| Genentech, Inc. | $2,100.00 | 10/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048240 | CMS |
| Genentech, Inc. | $2,600.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133048260 | CMS |
| Gilead Sciences, Inc. | $129.94 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133826129 | CMS |
| Gilead Sciences, Inc. | $2,400.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133599947 | CMS |
| GlaxoSmithKline, LLC. | $5,200.00 | 03/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115888942 | CMS |
| GlaxoSmithKline, LLC. | $2,925.00 | 03/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116638750 | CMS |
| GlaxoSmithKline, LLC. | $1,420.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116380822 | CMS |
| GlaxoSmithKline, LLC. | $1,420.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116207445 | CMS |
| GlaxoSmithKline, LLC. | $7,875.00 | 06/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115941603 | CMS |
| GlaxoSmithKline, LLC. | $358.53 | 06/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115998838 | CMS |
| GlaxoSmithKline, LLC. | $533.40 | 06/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116268946 | CMS |
| GlaxoSmithKline, LLC. | $193.02 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116708677 | CMS |
| GlaxoSmithKline, LLC. | $985.00 | 06/14/2024 | Grant | Undisputed | 01/23/2026 | 1116717455 | CMS |
| GlaxoSmithKline, LLC. | $750.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116347426 | CMS |
| Insmed, Inc. | $111.19 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089574980 | CMS |
| Insmed, Inc. | $3,750.00 | 03/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089581630 | CMS |
| Insmed, Inc. | $562.50 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089557004 | CMS |
| Insmed, Inc. | $67.53 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089571204 | CMS |
| Insmed, Inc. | $163.98 | 07/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089564208 | CMS |
| Insmed, Inc. | $2,250.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089557002 | CMS |
| Insmed, Inc. | $149.99 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089564212 | CMS |
| Insmed, Inc. | $63.14 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089582528 | CMS |
| Insmed, Inc. | $69.40 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089558928 | CMS |
| Janssen Research & Development, LLC | $4,550.00 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590213 | CMS |
| Janssen Research & Development, LLC | $3,250.00 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077589279 | CMS |
| Janssen Research & Development, LLC | $1,662.50 | 07/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077588917 | CMS |
| Janssen Research & Development, LLC | $1,950.00 | 07/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590211 | CMS |
| Janssen Research & Development, LLC | $261.66 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077588923 | CMS |
| Janssen Research & Development, LLC | $332.50 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077588925 | CMS |
| ModernaTX, Inc. | $650.00 | 01/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555505 | CMS |
| ModernaTX, Inc. | $3,500.00 | 01/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555507 | CMS |
| ModernaTX, Inc. | $1,775.00 | 04/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555473 | CMS |
| ModernaTX, Inc. | $11,250.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555493 | CMS |
| ModernaTX, Inc. | $2,000.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555499 | CMS |
| ModernaTX, Inc. | $975.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555511 | CMS |
| ModernaTX, Inc. | $5,250.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555515 | CMS |
| ModernaTX, Inc. | $650.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555537 | CMS |
| ModernaTX, Inc. | $6,500.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555539 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,225.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118840389 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,300.00 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118840391 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,625.00 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118840393 | CMS |
| Partner Therapeutics, Inc. | $710.00 | 02/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141329028 | CMS |
| PFIZER INC. | $6.30 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131272111 | CMS |
| SANOFI US SERVICES INC. | $3,550.00 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139696278 | CMS |
| SANOFI US SERVICES INC. | $8,520.00 | 07/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139696276 | CMS |
| UCB SA | $1,065.00 | 02/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950591 | CMS |
| UCB SA | $1,065.00 | 02/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950593 | CMS |
| UCB SA | $18,460.00 | 02/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950601 | CMS |
| UCB SA | $1,420.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950595 | CMS |
| UCB SA | $10,000.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950599 | CMS |
| UCB SA | $5,000.00 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950597 | CMS |
| Zambon USA Ltd. | $3,550.00 | 12/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147025013 | CMS |
| Zambon USA Ltd. | $102.75 | 12/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147025015 | CMS |
| Zambon USA Ltd. | $31.89 | 12/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147025017 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.